A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Trial details
- Registry ID
- NCT07096843
- Drugs studied
- budoprutug
TrialRedline tracks 2 clinical trials sponsored by Climb Bio, Inc.: 1 Phase 2, 1 Phase 1 / 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Phase 2 Study of Budoprutug in Subjects With Primary Membranous NephropathyNCT07096843 | budoprutug | Recruiting | 2027-10Estimated |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)NCT07564596 | Budoprutug | Recruiting | 2027-09Estimated |
Names as written in the registry records.